|
Originally published In Press as doi:10.1074/jbc.M304131200 on September 16, 2003
J. Biol. Chem., Vol. 278, Issue 48, 48204-48209, November 28, 2003
Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation*
David C. Willhite ,
Timothy L. Cover , and
Steven R. Blanke ¶
From the
Department of Biology and Biochemistry, University of Houston, 369 Science & Research Building II, Houston, Texas 77204-5001 and Departments of Medicine and Microbiology and Immunology, Vanderbilt University School of Medicine and Veterans Administration Medical Center, Nashville, Tennessee 37232-2605
Helicobacter pylori vacuolating toxin (VacA) is a secreted toxin that is reported to produce multiple effects on mammalian cells. In this study, we explored the relationship between VacA-induced cellular vacuolation and VacA-induced cytochrome c release from mitochondria. Within intoxicated cells, vacuolation precedes cytochrome c release and occurs at lower VacA concentrations, indicating that cellular vacuolation is not a downstream consequence of cytochrome c release. Conversely, bafilomycin A1 blocks VacA-induced vacuolation but not VacA-induced cytochrome c release, which indicates that cytochrome c release is not a downstream consequence of cellular vacuolation. Acid activation of purified VacA is required for entry of VacA into cells, and correspondingly, acid activation of the toxin is required for both vacuolation and cytochrome c release, which suggests that VacA must enter cells to produce these two effects. Single amino acid substitutions (P9A and G14A) that ablate vacuolating activity and membrane channel-forming activity render VacA unable to induce cytochrome c release. Channel blockers known to inhibit cellular vacuolation and VacA membrane channel activity also inhibit cytochrome c release. These data indicate that cellular vacuolation and mitochondrial cytochrome c release are two independent outcomes of VacA intoxication and that both effects are dependent on the formation of anion-selective membrane channels.
Received for publication, April 21, 2003
, and in revised form, September 8, 2003.
* This work was supported by the National Institutes of Health Grants RO1 AI45928 (to S. R. B.) and RO1 AI39657 (to T. L. C.), the Robert A. Welch Foundation (Grant E-1311), the American Heart Association (Grant 98BG472), and the Medical Research Service of the Department of Veterans Affairs. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed. Tel.: 713-743-8392; Fax: 713-743-8351; E-mail: sblanke{at}uh.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Kobayashi, H. Lee, J. Nakayama, and M. Fukuda
Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection
Glycobiology,
May 1, 2009;
19(5):
453 - 461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Tobin, G. T. Henehan, R. P. Murphy, J. C. Atherton, A. F. Guinan, S. W. Kerrigan, D. Cox, P. A. Cahill, and P. M. Cummins
Helicobacter pylori-induced inhibition of vascular endothelial cell functions: a role for VacA-dependent nitric oxide reduction
Am J Physiol Heart Circ Physiol,
October 1, 2008;
295(4):
H1403 - H1413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-R. Ki, H.-R. Lee, M.-J. Goo, I.-H. Hong, S.-H. Do, D.-H. Jeong, H.-J. Yang, D.-W. Yuan, J.-K. Park, and K.-S. Jeong
Differential regulation of ERK1/2 and p38 MAP kinases in VacA-induced apoptosis of gastric epithelial cells
Am J Physiol Gastrointest Liver Physiol,
March 1, 2008;
294(3):
G635 - G647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hisatsune, E. Yamasaki, M. Nakayama, D. Shirasaka, H. Kurazono, Y. Katagata, H. Inoue, J. Han, J. Sap, K. Yahiro, et al.
Helicobacter pylori VacA Enhances Prostaglandin E2 Production through Induction of Cyclooxygenase 2 Expression via a p38 Mitogen-Activated Protein Kinase/Activating Transcription Factor 2 Cascade in AZ-521 Cells
Infect. Immun.,
September 1, 2007;
75(9):
4472 - 4481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Clark and A. T. Maurelli
Shigella flexneri Inhibits Staurosporine-Induced Apoptosis in Epithelial Cells
Infect. Immun.,
May 1, 2007;
75(5):
2531 - 2539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kroemer, L. Galluzzi, and C. Brenner
Mitochondrial Membrane Permeabilization in Cell Death
Physiol Rev,
January 1, 2007;
87(1):
99 - 163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Terebiznik, C. L. Vazquez, K. Torbicki, D. Banks, T. Wang, W. Hong, S. R. Blanke, M. I. Colombo, and N. L. Jones
Helicobacter pylori VacA Toxin Promotes Bacterial Intracellular Survival in Gastric Epithelial Cells
Infect. Immun.,
December 1, 2006;
74(12):
6599 - 6614.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakayama, J. Hisatsune, E. Yamasaki, Y. Nishi, A. Wada, H. Kurazono, J. Sap, K. Yahiro, J. Moss, and T. Hirayama
Clustering of Helicobacter pylori VacA in Lipid Rafts, Mediated by Its Receptor, Receptor-Like Protein Tyrosine Phosphatase {beta}, Is Required for Intoxication in AZ-521 Cells
Infect. Immun.,
December 1, 2006;
74(12):
6571 - 6580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. McClain, D. M. Czajkowsky, V. J. Torres, G. Szabo, Z. Shao, and T. L. Cover
Random Mutagenesis of Helicobacter pylori vacA To Identify Amino Acids Essential for Vacuolating Cytotoxic Activity
Infect. Immun.,
November 1, 2006;
74(11):
6188 - 6195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Yamasaki, A. Wada, A. Kumatori, I. Nakagawa, J. Funao, M. Nakayama, J. Hisatsune, M. Kimura, J. Moss, and T. Hirayama
Helicobacter pylori Vacuolating Cytotoxin Induces Activation of the Proapoptotic Proteins Bax and Bak, Leading to Cytochrome c Release and Cell Death, Independent of Vacuolation
J. Biol. Chem.,
April 21, 2006;
281(16):
11250 - 11259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Torres, M. S. McClain, and T. L. Cover
Mapping of a Domain Required for Protein-Protein Interactions and Inhibitory Activity of a Helicobacter pylori Dominant-Negative VacA Mutant Protein
Infect. Immun.,
April 1, 2006;
74(4):
2093 - 2101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Genisset, C. L. Galeotti, P. Lupetti, D. Mercati, D. A. G. Skibinski, S. Barone, R. Battistutta, M. de Bernard, and J. L. Telford
A Helicobacter pylori Vacuolating Toxin Mutant That Fails To Oligomerize Has a Dominant Negative Phenotype
Infect. Immun.,
March 1, 2006;
74(3):
1786 - 1794.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Correa and B. G. Schneider
Etiology of Gastric Cancer: What Is New?
Cancer Epidemiol. Biomarkers Prev.,
August 1, 2005;
14(8):
1865 - 1868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Fitchen, D. P Letley, P. O'Shea, J. C Atherton, P. Williams, and K. R Hardie
All subtypes of the cytotoxin VacA adsorb to the surface of Helicobacter pylori post-secretion
J. Med. Microbiol.,
July 1, 2005;
54(7):
621 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. J. Torres, S. E. Ivie, M. S. McClain, and T. L. Cover
Functional Properties of the p33 and p55 Domains of the Helicobacter pylori Vacuolating Cytotoxin
J. Biol. Chem.,
June 3, 2005;
280(22):
21107 - 21114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Sundrud, V. J. Torres, D. Unutmaz, and T. L. Cover
Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
PNAS,
May 18, 2004;
101(20):
7727 - 7732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kim, A. K. Chamberlain, and J. U. Bowie
Membrane channel structure of Helicobacter pylori vacuolating toxin: Role of multiple GXXXG motifs in cylindrical channels
PNAS,
April 20, 2004;
101(16):
5988 - 5991.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|